Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15774 articles
Delta radiomics analysis of Magnetic Resonance guided radiotherapy imaging data can enable treatment response prediction in pancreatic cancer
Linear normalization of image intensity to median kidney value showed improved reproducibility of feature quantification.
»
12/15/21
The opposing action of stromal cell proenkephalin and stem cell transcription factors in prostate cancer differentiation
PENK caused down-regulation of scTF.
»
12/15/21
Flavonoids kaempferol and quercetin are nuclear receptor 4A1 (NR4A1, Nur77) ligands and inhibit rhabdomyosarcoma cell and tumor growth
Kaempferol and quercetin bind NR4A1 protein and inhibit NR4A1-dependent transactivation.
»
12/14/21
Evaluation of a 55-gene classifier as a prognostic biomarker for adjuvant chemotherapy in stage III colon cancer patients
Subclassification using 55GC and tumor sidedness revealed increased RFS.
»
12/14/21
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry
Low HER2-expression markedly more frequent in hormone-receptor(HR)+ subgroup.
»
12/14/21
Loss of epidermal MCPIP1 is associated with aggressive squamous cell carcinoma
In keratinocytes, RNase MCPIP1 essential for negative regulation of genes.
»
12/13/21
Extracellular HMGB1 interacts with RAGE and promotes chemoresistance in acute leukemia cells
Extracellular HMGB1 do upregulate autophagy.
»
12/21/21
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients
Overall survival before PS better for females.
»
12/20/21
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Epigenetic modulating agents may induce de novo expression of transcriptionally repressed tumor-associated antigens.
»
12/20/21
The oncogenic kinase NEK2 regulates an RBFOX2-dependent pro-mesenchymal splicing program in triple-negative breast cancer cells
NEK2 orchestrates pro-mesenchymal splicing program.
»
12/20/21
< Prev
Next >